Patel Sandip I — SEC insider filings

SEC reporting owner CIK 1843601. 13 insider filings on record with FilingPulse; latest filed 2026-10-16.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2021-02-09 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AtlasClear Holdings, Inc. (ATCH)CFO and General Counsel, Director52 legs · 100,000 sh · $20,740—7
Quantum FinTech Acquisition Corp (QFTA)Director21 leg · 501 sh · $5,178—1
Monterey Innovation Acquisition Corp (MTRY)Director, 10% owner1—1 leg · 570,000 sh · $3,4201
Akari Therapeutics Plc (AKTX)Director4——17
Peak Bio, Inc. (PKBO)Director1——7

Insider filings — Patel Sandip I

FiledFormIssuerReported transactionsSource
2026-10-164Akari Therapeutics Plc (AKTX)Grant/award (A): 12,100 @ $7.90 · Grant/award (A): 4,313 @ $7.90 · Option exercise (M): 3,866 @ $0.00 · Option exercise (M): 6,186 @ $0.00 · Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · +2 moreEDGAR
2026-10-024AtlasClear Holdings, Inc. (ATCH)Grant/award (A): 777,332 (derivative) @ $0EDGAR
2026-09-284AtlasClear Holdings, Inc. (ATCH)Grant/award (A): 50,000 @ $0.22 · Grant/award (A): 50,000 @ $0.20EDGAR
2026-09-284/AAtlasClear Holdings, Inc. (ATCH)Purchase (P): 50,000 @ $0.22 · Purchase (P): 50,000 @ $0.20EDGAR
2026-07-164AtlasClear Holdings, Inc. (ATCH)Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 731,030 (derivative) @ $0EDGAR
2025-12-184Akari Therapeutics Plc (AKTX)Purchase (P): 247,462 (derivative) · Purchase (P): 247,462 (derivative) @ $0.40 · Purchase (P): 154,664 (derivative) · Purchase (P): 154,664 (derivative) @ $0.40EDGAR
2025-04-294Akari Therapeutics Plc (AKTX)Grant/award (A): 44,642 @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12EDGAR
2025-03-244Akari Therapeutics Plc (AKTX)Grant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2024-11-184Peak Bio, Inc. (PKBO)Conversion (C): 763,316 · Disposition to issuer (D): 763,316 · Disposition to issuer (D): 67,735 · Disposition to issuer (D): 68,891 · Disposition to issuer (D): 47,364 · Conversion (C) · +1 moreEDGAR
2024-04-164AtlasClear Holdings, Inc. (ATCH)Other (J): 201,860 · Other (J): 354,088 (derivative) @ $0EDGAR
2024-02-164Quantum FinTech Acquisition Corp (QFTA)Disposition to issuer (D): 41,334EDGAR
2023-03-134Monterey Innovation Acquisition Corp (MTRY)Sale (S): 570,000 @ $0.01 · Other (J): 75,000EDGAR
2021-02-094Quantum FinTech Acquisition Corp (QFTA.U)Purchase (P): 501 @ $10.34EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1843601 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs